Abstract

Antigen (Ag)-presenting cells (APC) instruct CD4+ helper T (Th) cell responses, but it is unclear whether different APC subsets contribute uniquely in determining Th differentiation in pathogen-specific settings. Here, we use skin-relevant, fluorescently-labeled bacterial, helminth or fungal pathogens to track and characterize the APC populations that drive Th responses in vivo. All pathogens are taken up by a population of IRF4+ dermal migratory dendritic cells (migDC2) that similarly upregulate surface co-stimulatory molecules but express pathogen-specific cytokine and chemokine transcripts. Depletion of migDC2 reduces the amount of Ag in lymph node and the development of IFNγ, IL-4 and IL-17A responses without gain of other cytokine responses. Ag+ monocytes are an essential source of IL-12 for both innate and adaptive IFNγ production, and inhibit follicular Th cell development. Our results thus suggest that Th cell differentiation does not require specialized APC subsets, but is driven by inducible and pathogen-specific transcriptional programs in Ag+ migDC2 and monocytes.

Antigen presenting cells induce CD4+ T helper (Th) differentiation upon pathogen encounters. Here the authors use fluorescently-labeled bacteria, helminth and fungi to track and describe the functions of IRF4+ migratory type 2 dendritic cells and monocytes in the specific induction of Th1, Th2 or Th17 responses following skin inoculation.

Details

Title
Dermal IRF4+ dendritic cells and monocytes license CD4+ T helper cells to distinct cytokine profiles
Author
Hilligan, Kerry L 1   VIAFID ORCID Logo  ; Tang Shiau-Choot 2 ; Hyde, Evelyn J 2 ; Roussel Elsa 2   VIAFID ORCID Logo  ; Mayer, Johannes U 2   VIAFID ORCID Logo  ; Yang, Jianping 2 ; Wakelin, Kirsty A 2 ; Schmidt, Alfonso J 2 ; Connor, Lisa M 3 ; Sher, Alan 4   VIAFID ORCID Logo  ; MacDonald, Andrew S 5   VIAFID ORCID Logo  ; Ronchese Franca 2   VIAFID ORCID Logo 

 Malaghan Institute of Medical Research, Wellington, New Zealand (GRID:grid.250086.9) (ISNI:0000 0001 0740 0291); University of Otago Wellington, Department of Pathology and Molecular Medicine, Wellington, New Zealand (GRID:grid.29980.3a) (ISNI:0000 0004 1936 7830); National Institutes of Health, Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165) 
 Malaghan Institute of Medical Research, Wellington, New Zealand (GRID:grid.250086.9) (ISNI:0000 0001 0740 0291) 
 Malaghan Institute of Medical Research, Wellington, New Zealand (GRID:grid.250086.9) (ISNI:0000 0001 0740 0291); Victoria University of Wellington, School of Biological Sciences, Wellington, New Zealand (GRID:grid.267827.e) (ISNI:0000 0001 2292 3111) 
 National Institutes of Health, Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165) 
 University of Manchester, Manchester Academic Health Science Centre, Lydia Becker Institute of Immunology and Inflammation, Manchester Collaborative Centre for Inflammation Research, Faculty of Biology, Medicine and Health, Manchester, UK (GRID:grid.5379.8) (ISNI:0000000121662407) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2471541064
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.